Helius Medical Technologies Raises Over $500 Million in Funding to Launch SOL Treasury Company

Helius Medical Technologies has announced over $500 million in funding to launch a SOL treasury company. The funding comes from a private investment in public equity offering, where common stock is being purchased at $6.881 and stapled warrants to buy common shares are also being issued.

Helius Medical Technologies (NASDAQ: HSDT) has announced a significant strategic shift with the securing of over $500 million in funding to launch a SOL Treasury Company. The funding comes from a private investment in public equity (PIPE) offering, where common stock is being purchased at $6.881 and stapled warrants to buy common shares are also being issued Helius (NASDAQ:HSDT), in Partnership with Pantera Capital and Summer Capital Announces Over $500 Million in Funding to Launch SOL Treasury Company^[1].

The PIPE offering is led by Pantera Capital and Summer Capital and is expected to close around September 18, 2025. The proceeds will be used to implement a digital asset treasury strategy focused on acquiring SOL, Solana's native cryptocurrency, as its primary reserve asset. The initiative leverages Solana's position as the fastest-growing blockchain, processing 3,500+ transactions per second and offering a ~7% native staking yield Helius (NASDAQ:HSDT), in Partnership with Pantera Capital and Summer Capital Announces Over $500 Million in Funding to Launch SOL Treasury Company^[1].

The transaction is expected to close around September 18, 2025, with incoming leadership including Joseph Chee as Director and Executive Chairman, Cosmo Jiang as Board Observer, and Dan Morehead as Strategic Advisor. This leadership change signals a complete alignment with the new strategy, which aims to bridge traditional capital markets with the Solana ecosystem Helius (NASDAQ:HSDT), in Partnership with Pantera Capital and Summer Capital Announces Over $500 Million in Funding to Launch SOL Treasury Company^[1].

The deal structure is sophisticated, involving a $500 million PIPE offering with potential for an additional $750 million through warrant exercises, creating a vehicle that could deploy up to $1.25 billion into SOL tokens. The strategy follows the MicroStrategy model but with a key differentiator: unlike Bitcoin, SOL generates native yield through staking (~7%), providing Helius with a potential revenue stream beyond just asset appreciation Helius (NASDAQ:HSDT), in Partnership with Pantera Capital and Summer Capital Announces Over $500 Million in Funding to Launch SOL Treasury Company^[1].

The involvement of Clear Street as financial advisor is notable, as they have emerged as a significant player in institutional crypto trading infrastructure. The provision allowing investors to fund their purchase with SOL tokens directly indicates a sophisticated approach to capital formation that embraces both traditional and crypto-native capital Helius (NASDAQ:HSDT), in Partnership with Pantera Capital and Summer Capital Announces Over $500 Million in Funding to Launch SOL Treasury Company^[1].

The reverse stock split, announced on June 30, 2025, will reduce outstanding shares from approximately 33.8 million to 0.7 million, while maintaining the authorized share count at 150 million. This move aims to increase liquidity and reduce the number of shares outstanding Helius Med Technologies Inc Stock Price, News & Analysis^[2].

Helius Medical Technologies is transforming into a Solana treasury vehicle, fundamentally altering its business model. The company is becoming a leveraged play on Solana's cryptocurrency with a yield-generating capability, while maintaining a "conservative risk profile" to avoid higher-risk DeFi strategies Helius (NASDAQ:HSDT), in Partnership with Pantera Capital and Summer Capital Announces Over $500 Million in Funding to Launch SOL Treasury Company^[1].